Li Jialing, Xu Danghan, Liu Yingyu, Cao Yang, He Jun, Liao Muxi
The First Clinical School of Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Neurol. 2022 Jun 2;13:908282. doi: 10.3389/fneur.2022.908282. eCollection 2022.
Guillain-Barré syndrome(GBS) is an autoimmune-mediated peripheral neuropathy. Immune checkpoint inhibitors (ICIs) are the standard treatment for cancer and may lead to immune-related adverse events (irAEs) such as GBS. Corticosteroids, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are currently accepted treatments for ICI-induced GBS. However, there are still adverse reactions, and the effect of relieving symptoms is not as good as expected. Safe and effective complementary replacement therapy to alleviate GBS symptoms and ameliorate the quality of life is urgently required. In this case, a 63-year-old man received ICI therapy and antitumor chemotherapy for lung malignancy. After two courses of treatment, the patient gradually developed limb weakness, numbness, and pain at the ends of the limbs, with cerebrospinal fluid (CSF) albuminocytological dissociation, and electromyography (EMG) suggested demyelinating changes and was diagnosed as GBS. Although the patient received high doses of intravenous gamma globulin and limb weakness symptoms were alleviated, there was still significant numbness and pain in the extremities. After four times of acupuncture treatments, the patient complained that the symptoms of limb numbness and fatigue were significantly alleviated without any discomfort. This case report may provide a new alternative and complementary therapy for immune checkpoint inhibitor-induced GBS, but more definitive and robust evidence is needed to support its efficacy.
吉兰-巴雷综合征(GBS)是一种自身免疫介导的周围神经病。免疫检查点抑制剂(ICIs)是癌症的标准治疗方法,可能会导致诸如GBS等免疫相关不良事件(irAEs)。目前,皮质类固醇、血浆置换(PE)和静脉注射免疫球蛋白(IVIG)是治疗ICI诱导的GBS的公认方法。然而,这些治疗仍存在不良反应,且缓解症状的效果不如预期。迫切需要安全有效的补充替代疗法来缓解GBS症状并改善生活质量。在此病例中,一名63岁男性因肺恶性肿瘤接受了ICI治疗和抗肿瘤化疗。经过两个疗程的治疗后,患者逐渐出现肢体无力、麻木以及四肢末端疼痛,脑脊液(CSF)出现蛋白细胞分离,肌电图(EMG)提示脱髓鞘改变,被诊断为GBS。尽管患者接受了高剂量静脉注射丙种球蛋白治疗,肢体无力症状得到缓解,但四肢仍有明显的麻木和疼痛。经过四次针灸治疗后,患者称肢体麻木和乏力症状明显缓解,且无任何不适。本病例报告可能为免疫检查点抑制剂诱导的GBS提供一种新的替代和补充疗法,但需要更确凿有力的证据来支持其疗效。